Summer Dewdney

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

Bradley J. Monk, James Kauderer, Katherine Moxley et al. · Gynecologic Oncology · 2018 · 110 citations

Phase Ii Evaluation, Medicine, Cancer Management +9

The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the Society of Gynecologic Oncologists

Summer Dewdney, B.J. Rimel, Andrew J. Reinhart et al. · Gynecologic Oncology · 2010 · 86 citations

Neoadjuvant Chemotherapy, Gynecologic Oncologists, Medicine +8

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Kimberly K. Leslie, Virginia L. Filiaci, Adrianne Mallen et al. · Gynecologic Oncology · 2021 · 78 citations · Full text

Medicine, Cancer Management, Gynecology +9

<i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Kristina W. Thiel, Eric J. Devor, Virginia L. Filiaci et al. · Journal of Clinical Oncology · 2022 · 66 citations · Full text

A Delay from Diagnosis to Treatment Is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer

D.R. Dolly, Andreea Mihai, B.J. Rimel et al. · Frontiers in Oncology · 2016 · 54 citations · Full text